Name: K-CONNECT SUMMIT 2026
Start: 2026-05-08T00:00:00+07:00
End: 2026-05-10T23:59:59+07:00
Location: Shilla Monogram Quangnam Danang

K-CONNECT SUMMIT 2026

AI & Multi-omics – Shifting Paradigms in the New Era of Early Cancer Detection and Precision Oncology

The 2026 Summit is designed as a high-level academic forum bringing together regional and international leaders to discuss how ctDNA, multi-omics, AI integration, and comprehensive genomic profiling can be translated into structured, real-world oncology practice across the Asia-Pacific region.

K-CONNECT is part of the broader K-CONNECT PLATFORM, a regional initiative pioneered by Gene Solutions to connect oncologists, researchers, and healthcare professionals across Asia-Pacific. The platform is dedicated to fostering practical knowledge exchange, accelerating collaborative research, and driving innovation in cutting-edge fields including ctDNA (circulating tumor DNA)–MRD (Minimal Residual Disease) and Comprehensive Genomic & Transcriptomic Profiling (CGTP).

Through this summit, we aim to strengthen regional collaboration and advance the clinical implementation of precision oncology, particularly in integrating molecular data into routine screening, diagnosis, treatment decision-making, and disease monitoring.

Days

Hours

Minutes

Seconds

The event has ended. Thank you for your participation.

K-CONNECT APAC 2025

EMPOWERING THE POTENTIAL OF ctDNA-MRD

Gene Solutions, JSC

Gene Solutions envisions elevating healthcare in Asia through multi-dimensional genomics and AI, committed to accessible genetic testing services.

AGENDA

| K-CONNECT SUMMIT 2026

May 8

Day 01

Arrival and Welcome Reception

May 9

Day 02

Academic Day

08:00 – 09:00

Networking Activation

09:00 – 09:30

Opening

Associate Professor

Tu Do Anh

National Cancer Hospital (K Hospital)

Professor

Herbert Ho Fung Loong

The University of Hong Kong (HKU)

Opening Speech
Key Remarks

09:30 – 10:45

SESSION I: EARLY CANCER DETECTION (ECD)

Theme: ctDNA & AI – The Paradigm Shift in Early Cancer Screening in Modern Medicine

Professor

David CL Lam

The University of Hong Kong (HKU)

The Clinical Utility of ctDNA in Early Cancer Screening: Clinical Evidence & Real-world Practice

Professor

Sumei Cao

Sun Yat-sen University Cancer Center

Cancer Screening Strategies for High-Risk Populations: Practical Implementation Experience from Southern China

Doctor

Son Le Tran

Gene Solutions

Integrating AI Capabilities and Multi-omics ctDNA Analysis in Multi-Cancer Screening

Professor

Herbert Ho Fung Loong

The University of Hong Kong (HKU)

Cancer Screening in Modern Medicine: ctDNA Applications & Health Economic Perspectives

Panel Discussion

10:45 – 11:00

Coffee Break

11:00 – 12:30

SESSION II: EVIDENCE AND CLINICAL VALIDITY

Theme: Global Trends in Cancer Management: The Role of ctDNA and Comprehensive Genomic and Transcriptomic Profiling

Doctor

Vaibhav Choudhary

Nanavati Max Super Speciality Hospital, Mumbai

Comprehensive Genomic Profiling and ctDNA monitoring: Clinical Insights and Applications Across Solid Tumors

Doctor

Tu Ngoc Ly Lan

Principal Investigator, Gene Solutions

Multi-omics and AI in ctDNA Monitoring & CGTP: Technological Perspectives and Clinical Applications

Associate Professor

Vu Le Thuong

University Medical Center Ho Chi Minh City

Lung Cancer Clinical Case: Concurrent RNA and DNA Sequencing

Associate Professor

Huy Trinh Le

Hanoi Medical University Hospital

Gastrointestinal Cancer Clinical Case: The Role of ctDNA, TMB, and MSI-H in Treatment Selection

Panel Discussion

12:30 – 13:00

Lunch Break

13:45 – 15:00

SECTION III: PRECISION ONCOLOGY IN PRACTICE & FUTURE DIRECTIONS

From Treatment Decision to Longitudinal Follow-up: Implementing Precision Medicine in Real-world Oncology

Associate Professor

Lucksamon Thamlikitkul

Siriraj Hospital , Mahidol University

Maximizing Clinical Impact from Precision Oncology Data

Doctor

Basma MʼBarek, MD. Ph.D

Franco - Vietnamese Hospital

From Treatment Decision to Longitudinal Follow-up: The Role of ctDNA & MRD

Doctor

Tom Wei-Wu Chen, MD. Ph.D

National Taiwan University Hospital

Liquid Biopsy in Rare Cancers: The Promise of ctDNA Monitoring in Soft Tissue Sarcoma – Insights from MELODY

Doctor

Nguyen Duy Sinh, MD. Ph.D

Medical Oncologist, Oncology Medical Director, Gene Solutions

Implementing Precision Oncology in Daily Clinical Practice: From Present to Feature

Panel Discussion

15:15 – 15:25

Closing

Doctor

Hung Nguyen Thanh

Da Nang City Oncology Hospital

Closing Remarks & Program Summary

17:00 – 20:00

Gala Dinner

May 10

Day 03

Check-out

SPEAKERS & PANELISTS

Associate Professor

LIBRARY

Real-Time Molecular Surveillance in Colorectal Cancer: Lessons from a Challenging Case

Speakers:

Nguyen Thi Minh Phuong

Hong Ngoc Hospital – Phuc Truong Minh, Vietnam

Clinical Utility of ctDNA-MRD in NSCLC: Real-World Insights and Case Applications

Speakers:

kconnect.genesolutions.com huy trinh le cac bs k connect 2026 08 - The K-CONNECT Platform

Vu Le Thuong

University Medical Center Ho Chi Minh City

Real-World Application of ctDNA-MRD in Early-Stage Lung Adenocarcinoma: Two Clinical Case Analyses

Speakers:

Sutima Luangdilok

Chulalongkorn University, Thailand

Personalizing NSCLC Follow-Up and Treatment with ctDNA-MRD: Lessons from Practice

Speakers:

Sita Laksmi Andarini

National Referral for Repiratory diseases, RSUP Persahabatan

Real-World Evidence for ctDNA-MRD in Breast Cancer Management

Speakers:

Pornchai O-Charoenrat 

Chaophya Hospital, Thailand

Harnessing ctDNA-MRD to Guide Complex Treatment Decisions in Advanced HER2+ Breast Cancer

Speakers:

kconnect.genesolutions.com sita laksmi andarini kol samuelmrccc 512 photo - The K-CONNECT Platform

Samuel Haryono

Siloam MRCCC, Jakarta, Indonesia

The value of liquid biopsy at each stage of cancer care

Speakers:

Nick Pavlakis

University of Sydney, Australia

AI powered multi-omics ctDNA for early cancer screening: Analytical, prospective and real-world evidence

Speakers:

Son Le Tran

Gene Solutions

ctDNA-MRD in Action: Current Applications to Emerging Horizons

Speakers:

Aaron Tan Chia-Ken

National Cancer Centre Singapore

Advanced AI-driven Biomarkers: Integration in Precision Oncology

Speakers:

kconnect.genesolutions.com huy trinh le cac bs k connect 2026 07 - The K-CONNECT Platform

Herbert Ho Fung Loong

The University of Hong Kong (HKU)

Panel discussion and Q&A Bridging the gap in genomic insights across the Asia-Pacific region

Speakers:

Panel discussion and Q&A

Bridging the gap in genomic insights across the Asia-Pacific region

K-CONNECT SUMMIT 2026

AI & Multi-omics – Shifting Paradigms in the New Era of Early Cancer Detection and Precision Oncology

K-CONNECT APAC 2025

EMPOWERING THE POTENTIAL OF ctDNA-MRD

Gene Solutions, JSC

AGENDA

| K-CONNECT SUMMIT 2026

Theme: ctDNA & AI – The Paradigm Shift in Early Cancer Screening in Modern Medicine

Cancer Screening in Modern Medicine: ctDNA Applications & Health Economic Perspectives

Theme: Global Trends in Cancer Management: The Role of ctDNA and Comprehensive Genomic and Transcriptomic Profiling ​

From Treatment Decision to Longitudinal Follow-up: Implementing Precision Medicine in Real-world Oncology

SPEAKERS & PANELISTS

LIBRARY

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Speakers:

Upcoming videos will be released shortly

CASE STUDIES

Source:

JCO Oncology Advances

Cancer type:

Lung Cancer

Source:

JCO Oncology Advances

Cancer type:

Lung Cancer

Source:

JCO Oncology Advances

Cancer type:

Lung Cancer

Source:

JCO Oncology Advances

Cancer type:

Lung Cancer

Source:

JCO Oncology Advances

Cancer type:

Colorectal Cancer

Source:

JCO Oncology Advances

Cancer type:

Breast Cancer

K-CONNECT APAC 2025

Theme: Global Trends in Cancer Management: The Role of ctDNA and Comprehensive Genomic and Transcriptomic Profiling